IN8bio, Inc. Profile Avatar - Palmy Investing

IN8bio, Inc.

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologou…

Biotechnology
US, New York [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of INAB's Analysis
CIK: 1740279 CUSIP: 45674E109 ISIN: US45674E1091 LEI: - UEI: -
Secondary Listings
INAB has no secondary listings inside our databases.